June 15, 2010 article Open access Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database Annals of the Rheumatic Diseases DOI: 10.1136/ard.2009.114264 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 18 stored of 1,461 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST score 2026 Annals of the Rheumatic Diseases article Medicine Systemic Sclerosis and Related Diseases Open access 7 citations The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133) 2026 Annals of the Rheumatic Diseases article Medicine Systemic Sclerosis and Related Diseases Open access 6 citations Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 type A receptor in patients with systemic sclerosis 2025 RMD Open article Medicine Systemic Sclerosis and Related Diseases Open access 0 citations Fibrosis: cross-organ biology and pathways to development of innovative drugs 2025 Nature Reviews Drug Discovery review Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access 100 citations Quantitative 18F-FDG PET-CT can assess presence and extent of interstitial lung disease in early severe diffuse cutaneous systemic sclerosis 2024 Arthritis Research & Therapy article Medicine Systemic Sclerosis and Related Diseases Open access 12 citations Detection of Systemic Sclerosis-associated Interstitial Lung Disease by Exhaled Breath Analysis Using Electronic Nose Technology 2024 American Journal of Respiratory and Critical Care Medicine article Medicine Systemic Sclerosis and Related Diseases Open access 5 citations Troponin I levels in systemic sclerosis patients with myocardial involvement 2024 Journal of Scleroderma and Related Disorders article Medicine Systemic Sclerosis and Related Diseases Open access 3 citations Sex-specific difference in cardiac function in patients with systemic sclerosis: association with cardiovascular outcomes 2023 RMD Open article Medicine Systemic Sclerosis and Related Diseases Open access 5 citations Does the Impact of COVID ‐19 on Patients With Systemic Sclerosis Change Over Time? 2023 Arthritis Care & Research article Medicine Systemic Sclerosis and Related Diseases Open access 2 citations Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies 2023 RMD Open article Medicine Systemic Sclerosis and Related Diseases Open access 7 citations Evaluation of left cardiac chamber function with cardiac magnetic resonance and association with outcome in patients with systemic sclerosis 2022 Lara D. Veeken article Medicine Cardiovascular Function and Risk Factors Open access 11 citations Sclerodermic Cardiomyopathy—A State-of-the-Art Review 2022 Diagnostics article Medicine Systemic Sclerosis and Related Diseases Open access 23 citations Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis 2021 Arthritis & Rheumatology article Medicine Systemic Sclerosis and Related Diseases Open access 35 citations Anti‐C1q autoantibodies may not serve as an adequate biomarker for lung manifestations in systemic sclerosis: a single‐centre, cross‐sectional study 2021 British Journal of Dermatology article Medicine Systemic Sclerosis and Related Diseases Open access 1 citations A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol 2021 BMJ Open article Medicine Systemic Sclerosis and Related Diseases Open access 31 citations Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) 2020 Frontiers in Immunology article Medicine Systemic Sclerosis and Related Diseases Open access 24 citations Lung function is associated with minimal EQ-5D changes over time in patients with systemic sclerosis 2020 Clinical Rheumatology article Medicine Systemic Sclerosis and Related Diseases Open access 5 citations Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party 2020 Haematologica article Medicine Systemic Sclerosis and Related Diseases Open access cited by 2 patents 124 citations 18 results References 0